Cardinal Health, Inc.
NYSE:CAH
Positive Earnings Pre-Announcement
Cardinal Health Reports Second Quarter Fiscal Year 2023 Results
Published: 02/02/2023 13:04 GMT
Cardinal Health, Inc. (CAH) - Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance.
Fiscal Year 2023 Guidance Range for Non-GAAP Diluted Earnings per Share $5.20 to $5.50.
Q2 Earnings per Share View $1.14, Revenue View $50.74 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2023 Earnings per Share View $5.32 -- Refinitiv Ibes Data (analyst estimates).
Guidance Includes an Update to Fiscal Year 2023 Pharmaceutical Segment Profit Outlook to 4% to 6.5% Growth, From 2% to 5% Growth.
Fiscal Year 2023 Guidance Range for Non-GAAP Diluted Earnings per Share $5.20 to $5.50.
Q2 Earnings per Share View $1.14, Revenue View $50.74 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2023 Earnings per Share View $5.32 -- Refinitiv Ibes Data (analyst estimates).
Guidance Includes an Update to Fiscal Year 2023 Pharmaceutical Segment Profit Outlook to 4% to 6.5% Growth, From 2% to 5% Growth.
Revenue is expected to be $49.45 Billion
Adjusted EPS is expected to be $1.48
Next Quarter Revenue Guidance is expected to be $52.4 Billion
Next Quarter EPS Guidance is expected to be $1.47
More details on our Analysts Page.
Adjusted EPS is expected to be $1.48
Next Quarter Revenue Guidance is expected to be $52.4 Billion
Next Quarter EPS Guidance is expected to be $1.47
More details on our Analysts Page.